Population Pharmacokinetics Model and Simulation of Unbound and Total Valproic Acid in Epileptic Children Using a Protein Binding Model
Basic & Clinical Pharmacology & Toxicology · 2025
DOI: 10.1111/bcpt.70142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic & Clinical Pharmacology & Toxicology, 2025. Verfasst von Tingting Yue und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Valproic Acid, Anticonvulsants, Epilepsy, Models, Biological. Die Arbeit nennt 32 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province.
Themen: Simulation in der Pflegeausbildung, Kinderkrankenpflege
Abstract (Originalsprache)
Valproic acid (VPA), a classic antiepileptic drug with a narrow therapeutic window, is widely used in paediatric epilepsy treatment. As only the unbound fraction of the drug is a pharmacologically active component, we established a population pharmacokinetic (PopPK) model for both unbound and total VPA in epileptic children to provide a clinical optimisation strategy. A total of 450 epileptic children providing 620 samples were included for modelling development. In addition, trough unbound and total VPA concentrations were simulated for typical patients to propose the dose regimen. A one‐compartment model with first‐order absorption and elimination was well developed to describe the pharmacokinetic characteristics of unbound VPA, and the Langmuir equation was used to explore the protein binding parameters. The final model indicated that the CL u /F of unbound VPA was significantly influenced by body weight, age‐based maturation and daily dose. Proposed dosing regimens for children aged 0 to 12 years, simulated using the Monte Carlo method, recommended 10–30 mg/kg/day, decreasing with age. This PopPK model of VPA could be helpful to propose recommended dosage regimens to achieve the target therapeutic concentration window in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, China.
- Department of Pharmacy, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & the Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
- State Key Laboratory of Neurology and Oncology Drug Development, Jiangsu Simcere Pharmaceutical Co., Ltd., Nanjing, China.
ORCID-Profile: Tingting Yue, Ya'nan Chen
Förderung
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Yue, T., Zhao, L., Chen, Y., & Xu, S. (2025). Population Pharmacokinetics Model and Simulation of Unbound and Total Valproic Acid in Epileptic Children Using a Protein Binding Model. Basic & Clinical Pharmacology & Toxicology. https://doi.org/10.1111/bcpt.70142
Vancouver
Yue T, Zhao L, Chen Y, Xu S. Population Pharmacokinetics Model and Simulation of Unbound and Total Valproic Acid in Epileptic Children Using a Protein Binding Model. Basic & Clinical Pharmacology & Toxicology. 2025. doi:10.1111/bcpt.70142
BibTeX
@article{Yue2025,
author = {Yue, Tingting and Zhao, Limei and Chen, Ya'nan and Xu, Shansen},
title = {Population Pharmacokinetics Model and Simulation of Unbound and Total Valproic Acid in Epileptic Children Using a Protein Binding Model},
journal = {Basic & Clinical Pharmacology & Toxicology},
year = {2025},
doi = {10.1111/bcpt.70142}
}
EUVIMED